The global market for insulin alone is estimated to be $13.5 billion. Meanwhile, the 2009 market for insulin syringes and other delivery devices such as pens and injectors added another $1.1 billion while the market for insulin pumps equaled $1.6 billion worldwide.
The dominant players in insulin syringes and other delivery devices are Becton Dickinson, B. Braun, Abbott and Terumo. Â A number of other players round out the list, as shown below.
Source: MedMarket Diligence, LLC; Report #D510, “Diabetes Management: Products, Technologies, Markets and Opportunities Worldwide 2009-2018.”